Geron (NASDAQ:GERN) reported quarterly losses of $(0.05) per share which missed the analyst consensus estimate of $(0.03) by 47.06 percent. This is a 25 percent decrease over losses of $(0.04) per share from the same period last year. The company reported quarterly sales of $48.015 million which missed the analyst consensus estimate of $50.420 million by 4.77 percent. This is a 1.00 percent increase over sales of $47.538 million the same period last year.